Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Non-Current Deferred Tax Liability (2016 - 2024)

Lifecore Biomedical, Inc. \De\ has reported Non-Current Deferred Tax Liability over the past 14 years, most recently at $552000.0 for Q4 2024.

  • Quarterly results put Non-Current Deferred Tax Liability at $552000.0 for Q4 2024, up 32.69% from a year ago — trailing twelve months through Nov 2024 was $552000.0 (up 32.69% YoY), and the annual figure for FY2024 was $543000.0, up 42.89%.
  • Non-Current Deferred Tax Liability for Q4 2024 was $552000.0 at Lifecore Biomedical, Inc. \De\, up from $443000.0 in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for LFCR hit a ceiling of $36.5 million in Q2 2021 and a floor of $10000.0 in Q4 2022.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $579500.0 (2024), compared with a mean of $4.7 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: tumbled 99.65% in 2022 and later soared 4060.0% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Non-Current Deferred Tax Liability stood at $6.6 million in 2020, then crashed by 81.89% to $1.2 million in 2021, then tumbled by 99.17% to $10000.0 in 2022, then soared by 4060.0% to $416000.0 in 2023, then skyrocketed by 32.69% to $552000.0 in 2024.
  • The last three reported values for Non-Current Deferred Tax Liability were $552000.0 (Q4 2024), $443000.0 (Q3 2024), and $543000.0 (Q2 2024) per Business Quant data.